STAT3 and cancer: STAT3 activation by IL-6 has been shown to regulate MSC-induced chemoresistance, and the blockage of STAT3 activation (with AG490, a JAK2 inhibitor) improved the susceptibility of cancer cells to chemotherapeutic agents.